期刊文献+

6例PCI术后支架内血栓形成患者的原因分析及防治 被引量:4

The factors and preventive treatments of in-stent thrombosis post percutaneous coronary intervention
下载PDF
导出
摘要 目的分析PCI术后支架内血栓形成的病理生理机制、影响因素及防治策略。方法回顾性分析2012年1-7月我院心内科冠心病住院患者行PCI术后6例发生支架内血栓的基础病史、好发部位及危险因素。结果2012年1~7月,我院心内科共完成PCI术570例,6例患者(男性5例,女性1例)术后发生急性支架内血栓2例,亚急性支架内血栓4例,发生率1.0%。6例患者根据临床特点均行冠脉造影术+PCI术,其中1例术中发生低复流,冠脉内注人硝普钠、硝酸甘油、替罗非班,可见远段血栓影,予替罗非班强化治疗,出现心率、血压下降,予以临时起搏器治疗。术后6例患者均出现胸痛,除1例未予采集心电图外,其余5例心电图示相关血管支配的心肌sT段抬高。对临床高度疑诊患者均紧急行再次PCI术,其中4例造影证实支架内血栓(3例经血栓抽吸术后症状消失,TIMI达到3级,存活出院,1例因反复发生心力衰竭而最终死亡),余2例突发胸痛来不及行PCI术而死于心跳骤停。结论支架内血栓形成与患者临床特点、病变因素、支架因素、介人手术相关因素、药物因素相关,急诊介入手术是治疗支架内血栓的首选。 Objective To analyze the factors of in-stent thrombosis and to evaluate the efficacy of emergent percutaneous coronary intervention (PCI) for it. Methods Baseline and follow-up data of 570 patients who underwent PCI in our hospital from January to July 2012 were analyzed. Results 6 patients with coronary in-stent thrombosis were confirmed in 570 patients (1.0%). The in-stent thrombosis occurred from 4 hours to 8 days post PCI. Among these 6 patients, 6 patients presented recurrent chest pain, 3 patients manifested AMI, 2 patients suffered from cardiac arrests and 1 patient manifested heart failure. 4 patients were confirmed by emergent PCI and 1 diagnosed by electrocardiogram. 6 patients except 2 death patients were treated with emergent PCI (3 patients survived and 1 patients died). Conclusion The risk factors of in-stent thrombosis were clinical diseases, lesion type, intervention operating factors, stent and anticoagulant therapy. Emergent PCI arc the most effective methods for treating in-stent thrombosis.
出处 《中国心血管病研究》 CAS 2013年第7期504-507,共4页 Chinese Journal of Cardiovascular Research
关键词 经皮冠状动脉介入治疗 支架内血栓形成 Percutaneous coronary intervention In-stent thrombosis
  • 相关文献

参考文献11

  • 1张立新,张海滨,张正海,郭金成,马长生.国产药物洗脱支架在急诊冠脉介入治疗中导致急性支架内血栓形成的临床分析[J].中国心血管病研究,2008,6(5):358-360. 被引量:4
  • 2Trabattoni D, Fabbiocchi F, Montorsi P, et al. Stent thrombosis after sirolimus and paclitaxel eluting stent implantation in daily clinical practice: analysis of a single center registry. Catheter Car- diovase Interv, 2007,70 : 415-421.
  • 3Kereiakes DJ, Choo JK, Young JJ, et al. Thrombosis and drug-e- luting stents: a critical appraisal. Rev Cardiovase Med, 2004,5 : 9- 15.
  • 4Fenwei W, Stouffer GA, Waxman S, et al. Late coronary stent thrombosis: Early vs late stent thrombosis in the stent era. Com- mentary. Catheter Cardiovase Interv,2002,55:142-149.
  • 5Mauri L, I-Isieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007,356 : 1020-1029.
  • 6Ong AT, Hoye A, Aoki J, et al. Thirty day incidence and six.month clinical outcome of thrombotic stent occlusion after bare- metal, sirolimus, or paclitaxel stent implantation. J Am Coil Car- diol, 2005,45 : 947-953.
  • 7Cheneau E, Leborgne L, Mintz GS. Predictors of subacute stent thrombosis: result s of a systematic intravascular uh-rasound study. Circulation,2003,108:43-47.
  • 8陈立娟,马根山,冯毅,沈成兴,陈忠,章晓国.紫杉醇药物涂层支架治疗左前降支病变临床研究[J].东南大学学报(医学版),2006,25(6):423-426. 被引量:13
  • 9Cutlip DE, Windecker S, Mehran R, et al. Clinical end pointsin coronary stent trials:a case for standardized definitions. Circu- lation, 2007,115 : 2344-2351.
  • 10Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation, 2004, 109:1930-1932.

二级参考文献31

  • 1张立新,张海滨,高国旺,刘长虹,马长生.国产雷帕霉素药物洗脱支架在老年急性心肌梗死患者急诊冠状动脉介入治疗中的应用[J].中国心血管病研究,2006,4(6):426-428. 被引量:6
  • 2[1]Francesco S,Psdre A,Lee CH,et al.Sirolimos-eluting stent implantation in ST-segment elevation myocardial infarction.Cirelation,2003,108:1927-1929.
  • 3[3]Kastrati A,von Beckerath N,Jcost A,et al.Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy.Circulation,2004,110:1916-1919.
  • 4[4]von Beckerach N,Tanbert D,Pogatsa-Murray G,et al.Absotption,metabolizatian,and antiplatelet effects of 300-,600-,and 900-mg loading doses of clopidogrel:results of the ISARCHOICE(Intracoronary Stenting and Antithrombotie Regimen:Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect)Trial.Circulation,2005,112:2946-2950.
  • 5[5]Fujii K,Carlier SG,Minz GS,et al.Stent under-expansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation:An intravascular ultrasound study.J Am Coll Cardiol,2005,45:995-998.
  • 6Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA, 2002, 288: 2411-2420.
  • 7Chart AW, Molitemo DJ, Berger PB, et al. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tiroffixan and ReoProGive Similar Ettlcacy Outcome Trial (TARGET). J Am CollCardiol, 2003,42:1188-1195.
  • 8Muller I, Seyfarth M, Rudiger S, et al. Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart, 2001,85:92-93.
  • 9Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) TriM-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patient streated with recombinant tissue plasminogen activator and streptokinase.J Am Coil Cardiol, 1988,11:1-11.
  • 10Biondi-Zoeeai GG, Agostoni P, Testa L, et al. Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from a meta-analysis. Minerva Cardioangiol,2004,52:195-208.

共引文献67

同被引文献36

引证文献4

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部